Principal Investigator
Justin Watts
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230424
Clinical Trial Summary
Phase IA/B Combination Study of ADI-PEG 20,
Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia (AML)
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Leukemia
Contact Information
Phone Number
305-243-2647